Determinants of new onset cardiometabolic risk among normal weight children.


Journal

International journal of obesity (2005)
ISSN: 1476-5497
Titre abrégé: Int J Obes (Lond)
Pays: England
ID NLM: 101256108

Informations de publication

Date de publication:
04 2020
Historique:
received: 21 01 2019
accepted: 01 11 2019
revised: 18 09 2019
pubmed: 27 11 2019
medline: 3 8 2021
entrez: 27 11 2019
Statut: ppublish

Résumé

To identify determinants for the development of "normal weight metabolically unhealthy" (NWMU) profiles among previously metabolically healthy normal weight children. The QUALITY cohort comprises youth 8-10 years of age with a parental history of obesity (n = 630). Of these, normal weight children with no metabolic risk factors were identified and followed up 2 years later (n = 193). Children were classified as NWMU if they remained normal weight but developed at least one cardiometabolic risk factor. They were classified as normal weight metabolically healthy otherwise. Multivariable logistic regression models were used to identify whether adiposity (anthropometrics and DXA), lifestyle habits (physical activity, screen time, vegetables, and fruit- and sugar-sweetened beverages intake), fitness, and family history of cardiometabolic disease were associated with new onset NWMU. Of the 193 normal weight and metabolically healthy children at baseline, 45 (23%) became NWMU 2 years later (i.e., 48% had elevated HDL cholesterol, 13% had elevated triglycerides, and 4% had impaired fasting glucose). Changes in adiposity between baseline and follow-up were associated with an increased risk of NWMU for all adiposity measures examined (e.g., for ∆zBMI OR = 3.95; 95% CI: 1.76, 8.83). Similarly, a 2-year change in screen time was associated with incident NWMU status (OR = 1.24; 95% CI 1.04, 1.49). Children who increase their adiposity levels as they enter puberty, despite remaining normal weight, are at risk of developing cardiometabolic risk factors. Studies examining long-term consequences of NWMU profiles in pediatrics are needed to determine whether changes in screening practice are warranted.

Identifiants

pubmed: 31767973
doi: 10.1038/s41366-019-0483-0
pii: 10.1038/s41366-019-0483-0
pmc: PMC7101278
doi:

Substances chimiques

Blood Glucose 0
Cholesterol, HDL 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

781-789

Subventions

Organisme : CIHR
ID : OHF-69442
Pays : Canada
Organisme : CIHR
ID : NMD-94067
Pays : Canada
Organisme : CIHR
ID : MOP-97853
Pays : Canada
Organisme : CIHR
ID : MOP-119512
Pays : Canada

Références

Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23:469–80.
doi: 10.1111/j.1464-5491.2006.01858.x
De Ferranti SD, Osganian SK. Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus. Diab Vasc Dis Res. 2007;4:285–96.
doi: 10.3132/dvdr.2007.055
Magge SN, Goodman E, Armstrong SC. The metabolic syndrome in children and adolescents: shifting the focus to cardiometabolic risk factor clustering. Pediatrics. 2017;140:pii: e20171603. https://doi.org/10.1542/peds.2017-1603 .
doi: 10.1542/peds.2017-1603
Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362–74.
doi: 10.1056/NEJMoa031049
Ruderman NB, Schneider SH, Berchtold P. The “metabolically-obese,” normal-weight individual. Am J Clin Nutr. 1981;34:1617–21.
doi: 10.1093/ajcn/34.8.1617
Ding C, Chan Z, Magkos F. Lean, but not healthy: the ‘metabolically obese, normal-weight’ phenotype. Curr Opin Clin Nutr Metab Care. 2016;19:408–17.
doi: 10.1097/MCO.0000000000000317
Conus F, Allison DB, Rabasa-Lhoret R, St-Onge M, St-Pierre DH, Tremblay-Lebeau A, et al. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab. 2004;89:5013–20.
doi: 10.1210/jc.2004-0265
Conus F, Rabasa-Lhoret R, Peronnet F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab. 2007;32:4–12.
doi: 10.1139/h06-092
Yoo HJ, Hwang SY, Hong HC, Choi HY, Seo JA, Kim SG, et al. Association of metabolically abnormal but normal weight (MANW) and metabolically healthy but obese (MHO) individuals with arterial stiffness and carotid atherosclerosis. Atherosclerosis. 2014;234:218–23.
doi: 10.1016/j.atherosclerosis.2014.02.033
Eckel N, Muhlenbruch K, Meidtner K, Boeing H, Stefan N, Schulze MB. Characterization of metabolically unhealthy normal-weight individuals: risk factors and their associations with type 2 diabetes. Metabolism. 2015;64:862–71.
doi: 10.1016/j.metabol.2015.03.009
Guerrero-Romero F, Rodriguez-Moran M. Prevalence of dyslipidemia in non-obese prepubertal children and its association with family history of diabetes, high blood pressure, and obesity. Arch Med Res. 2006;37:1015–21.
doi: 10.1016/j.arcmed.2006.06.003
Guerrero-Romero F, Rodriguez-Moran M. Metabolically obese normal-weight children. World J Clin Pediatr. 2012;1:37–9.
doi: 10.5409/wjcp.v1.i4.37
Lambert M, Van Hulst A, O’Loughlin J, Tremblay A, Barnett TA, Charron H, et al. Cohort profile: the Quebec adipose and lifestyle investigation in youth cohort. Int J Epidemiol. 2012;41:1533–44.
doi: 10.1093/ije/dyr111
Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–94. Arch Pediatr Adolesc Med. 2003;157:821–7.
doi: 10.1001/archpedi.157.8.821
Henderson M, Van Hulst A, Von Oettingenn J, Benedetti A, Paradis G. Normal weight metabolically unhealthy phenotype in youth: do definitions matter? Pediatr Diabetes. 2018. https://doi.org/10.1111/pedi.12785 .
World Health Organisation (WHO). Growth reference data for 5–19 years; 2019. www.who.int/growthref/en/ . Last Accessed Nov 2019.
McCarthy HD, Jarrett KV, Crawley HF. The development of waist circumference percentiles in British children aged 5.0–16.9 y. Eur J Clin Nutr. 2001;55:902–7.
doi: 10.1038/sj.ejcn.1601240
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114 2 Suppl :555–76.
Samsell L, Regier M, Walton C, Cottrell L. Importance of android/gynoid fat ratio in predicting metabolic and cardiovascular disease risk in normal weight as well as overweight and obese children. J Obes. 2014;2014:846578.
doi: 10.1155/2014/846578
Colley R, Connor Gorber S, Tremblay MS. Quality control and data reduction procedures for accelerometry-derived measures of physical activity. Health Rep. 2010;21:63–9.
pubmed: 20426228
Colley RC, Garriguet D, Janssen I, Craig CL, Clarke J, Tremblay MS. Physical activity of Canadian children and youth: accelerometer results from the 2007 to 2009 Canadian Health Measures Survey. Health Rep. 2011;22:15–23.
pubmed: 21510586
Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc. 2008;40:181–8.
doi: 10.1249/mss.0b013e31815a51b3
Evenson KR. Calibration of two objective measures of physical activity for children. J Sports Sci. 2008;26:1557–65.
doi: 10.1080/02640410802334196
Trost SG, Loprinzi PD, Moore R, Pfeiffer KA. Comparison of accelerometer cut points for predicting activity intensity in youth. Med Sci Sports Exerc. 2011;43:1360–8.
doi: 10.1249/MSS.0b013e318206476e
Docherty D. Measurement in pediatric exercise science. Champaign, IL: Société canadienne de physiologie de l’exercice, Human Kinetics; 1996.
Johnson RK, Driscoll P, Goran MI. Comparison of multiple-pass 24-hour recall estimates of energy intake with total energy expenditure determined by doubly labeled water method in young children. J Am Diet Assoc. 1996;96:1140–4.
doi: 10.1016/S0002-8223(96)00293-3
Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291–303.
doi: 10.1136/adc.44.235.291
Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13–23.
doi: 10.1136/adc.45.239.13
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Critical Pathw Cardiol. 2005;4:198–203.
doi: 10.1097/00132577-200512000-00018
Zdrojewicz Z, Popowicz E, Szyca M, Michalik T, Smieszniak B. TOFI phenotype—its effect on the occurrence of diabetes. Pediatr Endocrinol Diabetes Metab. 2017;23:96–100.
doi: 10.18544/PEDM-23.02.0079
Wiklund P, Tormakangas T, Shi Y, Wu N, Vainionpaa A, Alen M, et al. Normal-weight obesity and cardiometabolic risk: a 7-year longitudinal study in girls from prepuberty to early adulthood. Obesity. 2017;25:1077–82.
doi: 10.1002/oby.21838
Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses’ Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6:714–24.
doi: 10.1016/S2213-8587(18)30137-2
Weiss R, Shaw M, Savoye M, Caprio S. Obesity dynamics and cardiovascular risk factor stability in obese adolescents. Pediatr Diabetes. 2009;10:360–7.
doi: 10.1111/j.1399-5448.2008.00504.x
Lurbe E, Garcia-Vicent C, Torro MI, Aguilar F, Redon J. Associations of birth weight and postnatal weight gain with cardiometabolic risk parameters at 5 years of age. Hypertension. 2014;63:1326–32.
doi: 10.1161/HYPERTENSIONAHA.114.03137
Van Hulst A, Barnett TA, Paradis G, Roy-Gagnon MH, Gomez-Lopez L, Henderson M. Birth weight, postnatal weight gain, and childhood adiposity in relation to lipid profile and blood pressure during early adolescence. J Am Heart Assoc. 2017; 6:pii: e006302. https://doi.org/10.1161/JAHA.117.006302 .
Lee S, Bacha F, Gungor N, Arslanian SA. Waist circumference is an independent predictor of insulin resistance in black and white youths. J. Pediatr. 2006;148:188–94.
doi: 10.1016/j.jpeds.2005.10.001
Brambilla P, Bedogni G, Moreno LA, Goran MI, Gutin B, Fox KR, et al. Crossvalidation of anthropometry against magnetic resonance imaging for the assessment of visceral and subcutaneous adipose tissue in children. Int J Obes. 2006;30:23–30.
doi: 10.1038/sj.ijo.0803163
Barnett TA, Kelly AS, Young DR, Perry CK, Pratt CA, Edwards NM, et al. Sedentary behaviors in today’s youth: approaches to the prevention and management of childhood obesity: a scientific statement from the american heart association. Circulation. 2018;138:e142–59.
doi: 10.1161/CIR.0000000000000591
Chooi YC, Ding C, Chan Z, Choo J, Sadananthan SA, Michael N, et al. Moderate weight loss improves body composition and metabolic function in metabolically unhealthy lean subjects. Obesity. 2018;26:1000–7.
doi: 10.1002/oby.22185
Dvorak RV, DeNino WF, Ades PA, Poehlman ET. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes. 1999;48:2210–4.
doi: 10.2337/diabetes.48.11.2210
Rodriguez-Moran M, Guerrero-Romero F, Aradillas-Garcia C, Violante R, Simental-Mendia LE, Monreal-Escalante E, et al. Obesity and family history of diabetes as risk factors of impaired fasting glucose: implications for the early detection of prediabetes. Pediatr Diabetes. 2010;11:331–6.
doi: 10.1111/j.1399-5448.2009.00590.x
Guerrero-Romero F, Aradillas-Garcia C, Simental-Mendia LE, Torres-Rodriguez ML, Mendoza Ede L, Rosales-Cervantes J, et al. Biochemical characteristics and risk factors for insulin resistance at different levels of obesity. Pediatrics. 2013;131:e1211–7.
doi: 10.1542/peds.2012-1421

Auteurs

Andraea Van Hulst (A)

Ingram School of Nursing, McGill University, Montreal, QC, Canada. andraea.vanhulst@mcgill.ca.

Marina Ybarra (M)

CHU Sainte-Justine Research Centre, Montreal, QC, Canada.
Institut Armand Frappier, Laval, QC, Canada.

Marie-Eve Mathieu (ME)

CHU Sainte-Justine Research Centre, Montreal, QC, Canada.
Department of Kinesiology, Université de Montréal, Montreal, QC, Canada.

Andrea Benedetti (A)

Department of Epidemiology Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.
Department of Medicine, McGill University, Montreal, QC, Canada.

Gilles Paradis (G)

Department of Epidemiology Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.

Mélanie Henderson (M)

CHU Sainte-Justine Research Centre, Montreal, QC, Canada. melanie.henderson.hsj@gmail.com.
Department of Pediatrics, Université de Montréal, Montreal, QC, Canada. melanie.henderson.hsj@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH